NORDIC BIOTECH INCENTIVE ApS: Financial statements 2025
CVR: 26277779
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NORDIC BIOTECH INCENTIVE ApS (CVR 26277779) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302. The solvency ratio was 96%.
- Gross Profit
- DKK -397,188
- Profit/Loss
- DKK -719,666
- Equity
- DKK 5,834,302
- Total Assets
- DKK 6,075,678
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -397K | -720K | 5.8M | 0 |
| 2024 | - | -243K | 4.9M | 6.6M | - |
| 2023 | - | 133K | -36K | 1.7M | - |
| 2022 | - | -18K | -2.3M | 1.7M | 0 |
| 2021 | - | -15K | -338K | 4M | 0 |
Official annual report
How creditworthy is NORDIC BIOTECH INCENTIVE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2024. Gross profit came to DKK -243,054, and the net result was DKK 4,871,034.
About NORDIC BIOTECH INCENTIVE ApS
NORDIC BIOTECH INCENTIVE ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company has been dissolved on 30 September 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.